Project Details
| Status | Active |
|---|---|
| Effective start/end date | 7/11/19 → 7/11/23 |
Funding
- Covance Inc. (Prot #LP0133-1275)
- LEO Pharma A/S (Prot #LP0133-1275)
Prot #LP0133-1275: Phase 2b Dose-Ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-Week Treatment Period in Adult Subjects with Atopic Dermatitis
- Liszewski, Walter Joseph (PD/PI)
- Silverberg, Jonathan I (Other)
Project: Research project